Swiss National Bank’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-178,800
| Closed | -$4.31M | – | 2700 |
|
|
2023
Q1 | $4.31M | Sell |
178,800
-8,300
| -4% | -$200K | ﹤0.01% | 1370 |
|
|
2022
Q4 | $1.98M | Buy |
187,100
+60,200
| +47% | +$636K | ﹤0.01% | 1900 |
|
|
2022
Q3 | $571K | Hold |
126,900
| – | – | ﹤0.01% | 2526 |
|
|
2022
Q2 | $508K | Buy |
126,900
+14,500
| +13% | +$58K | ﹤0.01% | 2607 |
|
|
2022
Q1 | $823K | Buy |
112,400
+7,600
| +7% | +$55.6K | ﹤0.01% | 2484 |
|
|
2021
Q4 | $589K | Hold |
104,800
| – | – | ﹤0.01% | 2636 |
|
|
2021
Q3 | $671K | Hold |
104,800
| – | – | ﹤0.01% | 2530 |
|
|
2021
Q2 | $883K | Sell |
104,800
-2,700
| -3% | -$22.7K | ﹤0.01% | 2525 |
|
|
2021
Q1 | $1.13M | Buy |
107,500
+18,400
| +21% | +$193K | ﹤0.01% | 2305 |
|
|
2020
Q4 | $1.51M | Buy |
89,100
+3,000
| +3% | +$50.8K | ﹤0.01% | 2071 |
|
|
2020
Q3 | $1.11M | Hold |
86,100
| – | – | ﹤0.01% | 2041 |
|
|
2020
Q2 | $1.22M | Buy |
+86,100
| New | +$1.22M | ﹤0.01% | 1993 |
|